[Pharmacotherapy of paroxysmal tachycardia].
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000517:prevention & control; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004206:Disopyramide / Q000627:therapeutic use; D006333:Heart Failure / Q000517:prevention & control; D006801:Humans; D011802:Quinidine / Q000627:therapeutic use; D013614:Tachycardia, Paroxysmal / Q000188:drug therapy*; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D004071:Digitalis Glycosides; D014700:Verapamil; D004206:Disopyramide; D011802:Quinidine
Pharmakotherapie der paroxysmalen Tachykardie.